|
|
 |
|
MAPP: Map Pharmaceuticals Inc - Stock News |
Enter Ticker:
|
|
| Nov 12, 2009 |
Stock-PR.com Announces Daily Stock Watch |
| Nov 12, 2009 |
Crown Equity Holdings, Inc.: CRWENews Highlights: UEC, MAPP, VRMLQ |
| Nov 12, 2009 |
MAP Pharmaceuticals Secures $60 Million Committed Equity Financing Facility |
| Nov 11, 2009 |
MAP Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare Conference |
| Nov 06, 2009 |
BiomedReports: News and FDA Updates for Isis (Nasdaq:ISIS), VIVUS (Nasdaq:VVUS), MAP (Nasdaq:MAPP) |
| Nov 05, 2009 |
MAP Pharmaceuticals Reports Third Quarter of 2009 Financial Results |
| Oct 29, 2009 |
MAP Pharmaceuticals Completes Interim Safety Review of LEVADEX(TM) Open-Label Safety Extension in More Than 400 Patients |
| Sep 22, 2009 |
'Headache' Publication Describes Potential Mechanistic Rationale for LEVADEX(TM) Favorable Adverse Event Profile |
| Sep 10, 2009 |
MultiVu Video Feed: POSITIVE PHASE 3 TRIAL DATA FOR INVESTIGATIONAL NEW MIGRAINE TREATMENT PRESENTED IN LATE-BREAKING SESSION AT 14th ANNUAL INTERNATIONAL HEADACHE SOCIETY CONGRESS |
| Sep 10, 2009 |
MAP Pharmaceuticals' Analysis of Positive Phase 3 LEVADEX(TM) Data To Be Presented in Late-Breaking Session at 14th Congress of the International Headache Society |
| Sep 08, 2009 |
MAP Pharmaceuticals (MAPP) Bullish Technical Alert - Trend Up 17.1% |
| Sep 02, 2009 |
MAP Pharmaceuticals to Present at Upcoming Healthcare and Scientific Conferences |
| Aug 19, 2009 |
MAP Pharmaceuticals (MAPP) Bullish Technical Alert - Trend Up 8.1% |
| Aug 10, 2009 |
MAP Pharmaceuticals (MAPP) Bullish Technical Alert - Trend Up 14.5% |
| Aug 06, 2009 |
MAP Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock |
| |
| ZACKS COMMENTARY FOR MAPP |
|
|
|
Sponsored Links 
-0.06